Agilent awarded patent for comparative genomic hybridization methods Agilent Technologies Inc.

Agilent’s higher-resolution platform allows users to detect much smaller sized genomic aberrations throughout complex genomes. ‘We are excited by the latest intellectual house supporting our market-leading CGH array,’ said Robert Schueren, Agilent vice president, Genomics. ‘This displays Agilent’s continued investment in and commitment to the cytogenetics medical research space.’.. Agilent awarded patent for comparative genomic hybridization methods Agilent Technologies Inc. today announced that it had been awarded a significant patent for comparative genomic hybridization strategies. CGH methods help researchers study genetics and tumor in both simple and clinical research.S. Patent has claims for measuring copy number changes in genomic DNA, covering both one-color and two-color assays using oligonucleotide probes and samples with high-sequence complexity, such as human being genomic DNA samples.The grant is definitely area of the Tufts Health Plan Base's concentrate on healthy ageing for older adults 60+. The foundation is in its fifth year of funding applications that promote old adult health. This grant is part of its Wellness & Wellness programming, which makes a speciality of promoting chronic disease self-management and prevention, nutrition and exercise, and fall prevention. By focusing our grantmaking on healthful aging, we've been able to make a thoughtful design of offering that helps older adults inside our communities live even more meaningful lives, stated Jim Roosevelt, President of the Tufts Health Plan CEO and Base of Tufts Health Plan.